Oral Therapies for Multiple Myeloma Continuum


Oral Therapies for Multiple Myeloma

Perception Is Patients’ Reality: How to Increase Oral Oncolytic Adherence

Yelak Biru, MSc 

From 2004 to 2013, 22 new oral anticancer medications were introduced in the United States, which is almost the same number (27) of oral anticancer medications that were introduced in [ Read More ]

Oral Therapies for Multiple Myeloma

Nurse Navigators Promote Patient Adherence to Treatment Plan

Deborah Christensen, RN, BSN, HNB-BC, Oncology Nurse Navigator, Dixie Regional Medical Center, St. George, UT 

Oral therapies for treating cancer are being developed at an unprecedented rate. Oncology providers, nurses, and pharmacists are now challenged with effectively helping patients manage their cancer treatments in the [ Read More ]

Oral Therapies for Multiple Myeloma

Changing Patient Perceptions to Promote Adherence to Oral Antimyeloma Oncolytics

Sabby Muneer, PhD 

The management of multiple myeloma (MM) is undergoing a seismic shift from acute treatment to a chronic care model that requires long-term treatment. This trend is fueled by the availability [ Read More ]

Oral Therapies for Multiple Myeloma

Managing Patient Perceptions of Oral Anticancer Therapies

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

For many years, patients with multiple myeloma have been visiting an infusion facility to receive their cancer treatments. Although patients love their oncology team, trips to the infusion facility can [ Read More ]

Conquering the Multiple Myeloma Continuum

A New Era of Oral Therapies for Multiple Myeloma : Implementing routines and strategies to promote adherence

Sabby Muneer, PhD 

Recent advancements in the treatment of multiple myeloma (MM) have led to significant improvements in patient outcomes, including unprecedented survival rates.1 Such progress has allowed a paradigm shift toward a [ Read More ]

Conquering the Multiple Myeloma Continuum

Incorporating Oral Therapy Compliance into the Routine of Patients with Myeloma

Cindy Chmielewski, Patient Advocate and Mentor 

Oral oncolytics represent 25% to 35% of the drugs in the oncology pipeline.1 They are patient friendly, allow patients to manage their treatment, and overall, have a less disruptive effect [ Read More ]

Conquering the Multiple Myeloma Continuum, Oral Therapies for Multiple Myeloma

How to Communicate with Patients with Myeloma to Achieve the Best Outcomes

Deborah Christensen, RN, BSN, HNB-BC, Oncology Nurse Navigator, Dixie Regional Medical Center, St. George, UT 

Treating cancer with oral medications that are taken at home sounds like a great idea, and it is, once adherence barriers are addressed. Likewise, years ago it was unthinkable that [ Read More ]

Conquering the Multiple Myeloma Continuum

Navigators Are Key in Encouraging Oral Therapy Adherence

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

Welcome to our first newsletter in the Conquering the Multiple Myeloma Continuum series, which focuses on adherence to oral medications in patients with multiple myeloma (MM). In this first newsletter, [ Read More ]